News RSS Bioethics News.

05/01/2018

Federal appeals court hears CRISPR patent dispute

External Link - Source: Science

Here’s a double-negative brain twister with potentially huge financial ramifications and a Nobel Prize resting on the answer: For an invention to be “nonobvious”—and therefore patentable in the United States—should there be no guarantee of success when researchers embark on experiments that lead to the invention? That mind-bending question was the centerpiece of a case heard today by the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., over the lucrative patent portfolio surrounding the revolutionary genome editor commonly known as CRISPR.

This entry was posted in Technology and tagged . Bookmark the permalink.